RNAC

RNAC Deferred Revenue

$0.00Quarterly · USD

Period ending:

RNAC FY Deferred RevenueUSD
RNAC FY Deferred Revenue2014-12-31: $3.02M2015-12-31: $1.31M2016-12-31: $1.84M2017-12-31: $787.00K2018-12-31: $959.00K2019-12-31: $1.67M2020-12-31: $72.05M2021-12-31: $53.88M2022-12-31: $593.00K2023-12-31: $2.31M2024-12-31: $0.002025-12-31: $0.00$72.05M$0.00
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RNAC deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Cartesian Therapeutics Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
0
0
2,311,000
593,000
53,883,000
72,050,000
1,674,000
959,000
787,000
1,836,000
1,313,000
3,018,000

Compare deferred revenue

All RNAC financial metrics · RNAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.